Specify a stock or a cryptocurrency in the search bar to get a summary
Asarina Pharma AB (publ)
ASAPAsarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its's product is Sepranolone, which is used for the treatment of allopregnanolone-induced stress- and compulsivity-driven disorders from Tourette syndrome to Obsessivecompulsive disorder syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. The company was incorporated in 2005 and is based in Solna, Sweden. Address: Karolinska Institutet Science Park, Solna, Sweden, 171 65
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ASAP
Dividend Analytics ASAP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ASAP
Stock Valuation ASAP
Financials ASAP
Results | 2019 | Dynamics |